CONTRIBUTION OF MOLECULAR TYPING METHODS AND ANTIFUNGAL SUSCEPTIBILITY TESTING TO THE STUDY OF A CANDIDEMIA CLUSTER IN A BURN CARE UNIT

被引:32
作者
BARTDELABESSE, E
VANDEVENTER, H
GOESSENS, W
POIROT, JL
LIORET, N
VANBELKUM, A
DROMER, F
机构
[1] INST PASTEUR, UNITE MYCOL, F-75724 PARIS 15, FRANCE
[2] HOP ST ANTOINE, CTR BRULES, PARASITOL MYCOL LAB, PARIS, FRANCE
[3] UNIV HOSP DIJKZIGT, DEPT BACTERIOL, ROTTERDAM, NETHERLANDS
关键词
D O I
10.1128/JCM.33.12.3278-3283.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We investigated a cluster of cases of Candida septicemia diagnosed in four burn patients, Twenty clinical isolates of Candida albicans and two of Candida parapsilosis, plus eight isolates of C. albicans recovered from nurses' clothes, were analyzed by antifungal susceptibility testing and three genotyping methods (restriction fragment length polymorphism analysis with EcoRI and Hinfl, arbitrarily primed PCR, and karyotyping). The high MICs of the azoles for all of the C. albicans isolates tested suggest either a natural resistance of the endogenous flora or the transmission of isolates with acquired resistance, The genotyping methods demonstrated the involvement of four different strains, cross-infections with one C. albicans strain and one C. parapsilosis strain, and identity between some of the strains from the patients and nurses, The origins of the strains remain unclear, Our results show that the use of a combination of at least two different methods such as those used in the present study is recommended for C. albicans typing.
引用
收藏
页码:3278 / 3283
页数:6
相关论文
共 26 条
[1]   CORRELATION BETWEEN IN-VITRO AND IN-VIVO ACTIVITY OF ANTIFUNGAL AGENTS AGAINST CANDIDA SPECIES [J].
ANAISSIE, EJ ;
KARYOTAKIS, NC ;
HACHEM, R ;
DIGNANI, MC ;
REX, JH ;
PAETZNICK, V .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :384-389
[2]   CANDIDA-ALBICANS GENOTYPING IN STUDIES WITH PATIENTS WITH AIDS DEVELOPING RESISTANCE TO FLUCONAZOLE [J].
BARTDELABESSE, E ;
BOIRON, P ;
CARLOTTI, A ;
DUPONT, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (11) :2933-2937
[3]  
BECQSAGUE CM, 1993, J INFECT DIS, V167, P1247
[4]  
DUPONT B, 1992, FR INFEC D, V4, P290
[5]   FLUCONAZOLE CONCENTRATIONS IN SALIVA FROM AIDS PATIENTS WITH OROPHARYNGEAL CANDIDOSIS REFRACTORY TO TREATMENT WITH FLUCONAZOLE [J].
GARCIAHERMOSO, D ;
DROMER, F ;
IMPROVISI, L ;
PROVOST, F ;
DUPONT, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :656-660
[6]   ISOLATION OF FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS FROM HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE PATIENTS NEVER TREATED WITH AZOLES [J].
GOFF, DA ;
KOLETAR, SL ;
BUESCHING, WJ ;
BARNISHAN, J ;
FASS, RJ .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) :77-83
[7]  
HUNTER PR, 1990, J MED VET MYCOL, V28, P317
[8]   GENETIC ASSOCIATION OF MATING TYPES AND VIRULENCE IN CRYPTOCOCCUS-NEOFORMANS [J].
KWONCHUNG, KJ ;
EDMAN, JC ;
WICKES, BL .
INFECTION AND IMMUNITY, 1992, 60 (02) :602-605
[9]   STRAIN AND SPECIES IDENTIFICATION BY RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN THE RIBOSOMAL DNA REPEAT OF CANDIDA SPECIES [J].
MAGEE, BB ;
DSOUZA, TM ;
MAGEE, PT .
JOURNAL OF BACTERIOLOGY, 1987, 169 (04) :1639-1643
[10]  
MEUNIER R, 1992, CLIN INFECT DIS S1, V14, pS120